Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
seattle blog main
5
×
seattle top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
augmented reality
axonvr
cancer
construction
deako
eli lilly
game studios
gift cards
halo
haptx
healionics
hemodialysis
What
year
5
×
based
businesses
capital
companies
drug
drugs
february
haptx
illumagear
investments
modumetal
month
past
plan
price
raised
seattle
seen
shortest
technology
therapies
venture
watch
weeks
alzheimer’s
answer
approval
arguments
away
big
bio
class
commercialized
competitors
decades
democratic
dems
different
discontent
Language
unset
Current search:
year
×
" seattle blog main "
×
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Seattle Venture Capital Watch: Modumetal, Illumagear, HaptX & More
@xconomy.com
5 years ago
Seattle Venture Capital Watch: Modumetal, Illumagear, HaptX & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
